D[ifferentiation]{.smallcaps} of the somatic musculature of the *Drosophila* embryo is a complex, multistep process, resulting in a segmentally reiterated pattern of muscles that govern larval locomotion via muscle connections to discrete attachment sites in the epidermis. After initial periods of independent differentiation, the mesodermally derived muscle cells and the epidermal attachment cells use a complex signaling mechanism, through which connections between the two cell types and final differentiation are achieved.

During the second half of *Drosophila* embryogenesis, each of the specific somatic myotubes extends its leading edge towards a specific location, at which a group of epidermal muscle attachment (EMA)^1^ cells is located. At the end of this extension process, each myotube forms a physical contact with a specific EMA cell, which is then induced to develop into a mature tendon cell ([@B6]; [@B7]).

The larval tendon cells develop in the embryo in two sequential steps: initially, a subset of ectodermally derived competent EMA cells is defined along the A-P and D-V axes. In a second step, the portion of these competent cells that are bound to muscles differentiate into mature tendon cells ([@B7]). The expression of the regulatory protein Stripe, a transcription factor of the early growth response (EGR) family, determines the fate of the EMA competent cells at the first phase of tendon cell development ([@B28]; [@B19]). Stripe expression leads to the expression of an array of EMA-specific genes that contribute to the correct guidance of the myotubes ([@B7]; Vorbrüggen et al., 1997).

The second phase of tendon cell differentiation depends on inductive interactions between the myotube and the EMA cell. These interactions lead to terminal differentiation of the EMA competent cells into tendon cells, in which high protein levels of Stripe, Groovin ([@B46]), and Alien ([@B22]) are maintained, and the transcription of the genes *delilah* ([@B3]) and *β1 tubulin* ([@B12]) is induced.

The inductive signal responsible for triggering the muscle-dependent differentiation of the tendon cells is provided by Vein, a secreted protein that is homologous to vertebrate neuregulins ([@B37]). Vein is necessary and sufficient to induce the expression of tendon-specific genes, including *stripe*, *groovin*, *delilah*, and *β1 tubulin* ([@B50]). Vein activity is mediated through its activation of the *Drosophila* EGF receptor homologue, DER, expressed on the EMA cells ([@B50]; [@B38]). Thus, Vein acts as a secreted differentiation factor that mediates the muscle-dependent differentiation of the EMA cells into tendon cells.

Although *vein* mRNA is produced in the muscle cells, Vein protein is highly concentrated in the intercellular space between the muscles and the tendon cells, where intense adherens type junctions are formed ([@B50]). This junctional space contains electron-dense material, which presumably represents protein aggregates of various extracellular matrix components ([@B44]). Since the primary sequence of Vein includes a signal peptide but no transmembrane domain, it is assumed that Vein protein is secreted from the myotube and accumulates at the muscle--tendon junctional space. The molecular mechanism that is responsible for Vein localization at this site is yet to be elucidated. The Vein ligand is a relatively weak activator of the EGF receptor pathway ([@B38]; [@B51]); therefore, a mechanism regulating Vein accumulation at the site of activity may be essential for a proper activation of the pathway.

This paper describes the molecular cloning and functional analysis of the EMA-specific gene *groovin* (*grv*), which is identical to *kakapo* ([@B31]). *kakapo* (*kak*) has been previously identified in a genetic screen for mutations that cause wing blisters. This phenotype results from impaired adhesion between the dorsal and ventral wing epithelia ([@B31]). Kak is a large intracellular protein, expressed mainly along the EMA cell plasma membrane. The primary sequence of Kak exhibits sequence motifs that indicate its possible association with the cytoskeleton of the EMA cell. Analysis of *kak* mutant embryos shows that *kak* is essential for proper completion of the muscle-dependent tendon cell differentiation program. Our results suggest that the primary role of Kak is to mediate the restricted localization and accumulation of Vein protein at the muscle--tendon junctional site.

Materials and Methods {#MaterialsMethods}
=====================

Fly Strains
-----------

Fly stocks used were *y w* (used as a "wild-type" strain). Df(2R)MK1 = Df (2R) 50B3-5;50D1-4 was provided by V. Harternstein (University of California, Los Angeles, CA). *b pr cn bw* was provided by J. Campos-Ortega (University of Köln, Germany) and was isogenized in our lab. P{*ry* ^+17.2^ = neo-FRT} 42D; *ry* ^605^ (referred to as FRT42D in this paper) was provided by the Bloomington stock center (Bloomington, IN). FRT42DV104/SM5 (referred to as V104 or *kak^V104^* in this paper) was provided by N. Brown (Cambridge University, UK; [@B48]). Seven alleles of *kak* ([@B31]) were obtained from J. Fristrom and M. Prout (University of California, Berkeley, CA). *kak^A405^* was generated in our lab by repetitive EMS mutagenesis (screen for lethal mutations over Df(2R)MK1; see below).

EMS mutagenesis was performed essentially as described in [@B21]. Isogenized *b pr cn bw* males were EMS mutagenized and their F1 male progeny were tested for lethality over Df(2R)MK1. *kak^A405^* was generated in this screen.

Immunochemical Reagents and DNA Probes for Whole Mount In Situ Hybridization
----------------------------------------------------------------------------

Primary antibodies: anti-Groovin monoclonal antibody (mAb\#19) was raised in mice immunized with *Drosophila* embryonic membrane proteins (\>100 kD) ([@B46]). Hybridomas were screened by immunostaining and selected according to their staining pattern. Although mAb\#19 reacts specifically with the Kak COOH terminus protein sequence (as shown in Results), we found that it cross-reacts with additional, Kak-unrelated epitope(s) present along the embryonic segmental grooves. Polyclonal anti-Kak antibodies were generated in guinea pigs by immunizing with a Kak--glutathione-S-transferase (GST) fusion protein (containing the Kak sequence encoded by a 4.6-kbp fragment of *kak* cDNA \[position 6394--10993, encoding amino acids 2136--3668\]). Polyclonal anti-Stripe ([@B7]), anti-Vein, and anti-Delilah antibodies were prepared in our lab ([@B50]).

Rabbit anti-myosin heavy chain antibodies were obtained from P. Fisher (SUNY, Stony Brook, NY). Secondary antibodies used included: Cy3-conjugated anti--guinea pig and anti--rat fluorescein-conjugated anti-- rabbit, and HRP-conjugated anti--rabbit and anti--mouse IgM antibodies (Jackson ImmunoResearch, West Grove, PA).

Nonradioactive digoxygenin-labeled DNA probes for various *kak* cDNA fragments and a *β1 tubulin* fragment (D. Buttgereit, University of Marburg, Germany) were used for whole embryo in situ hybridization.

Histochemical Staining
----------------------

For sectioning, embryos were first stained with anti-Kak polyclonal antibody and then embedded in JB-4 embedding media (Polysciences, Inc., Warrington, PA) as described ([@B45]). Sections (3--4-μm width) were examined under a Zeiss Axioscope microscope (Thornwood, NY).

Whole Mount Embryonic Staining
------------------------------

Antibody staining was performed essentially as described previously ([@B5]), except that the embryos were fixed with 3% paraformaldehyde. In situ hybridization was performed by the method of [@B43] using a digoxygenin-labeled DNA probe.

Western Analysis
----------------

Western analysis was performed according to standard procedures and is described in [@B45]. SuperSignal chemiluminescent substrate (Pierce Chemical Co., Rockford, IL) was used for signal detection.

For Western blot analysis of single embryos, *kak^V104^*/+ flies were produced and crossed with each other. The embryos of this cross were incubated for 25 h in 25°C, and each of the nonhatched embryos was boiled in sample buffer and subjected to SDS-PAGE in a single lane. The truncated band (Fig. [4](#F4){ref-type="fig"} *D*) is representative of seven individual embryos.

Expression of FLAG-tagged Kakapo
--------------------------------

The *kak* cDNA insert was amplified by PCR from phage Φ43d and subcloned in pECE-FLAG (SmaI-XbaI). 293 cultured human cells were transfected with 20 μg of the above construct by the standard calcium phosphate transfection method. Transfected and nontransfected cells were harvested 48 h after transfection and lysed, and the resulting protein extracts were immunoprecipitated with anti-FLAG antibodies coupled to agarose beads (anti-FLAG M2 affinity gel; Kodak No. IB13021). Immunoprecipitated proteins were eluted in sample buffer and resolved on 7.5% SDS-PAGE, followed by Western analysis using mAb\#19.

Preparation of Fly Genomic DNA and Southern Analysis
----------------------------------------------------

FRT42DV104/SM5 flies were crossed to *b pr cn bw* flies to out-cross SM5. Genomic fly DNA was prepared from FRT42DV104/*b pr cn bw* progeny of the above cross and from the FRT42D and *b pr cn bw* lines, according to standard procedure. The genomic DNA was subjected to Southern analysis using genomic probes. The probes were amplified by PCR using *Taq* DNA polymerase (D1806; Sigma Chemical Co., St. Louis, MO) on genomic DNA of homozygous FRT42D flies. The following primers were used (see also Fig. [4](#F4){ref-type="fig"} *A*): primer A: 5′-CTGTTATGGTGCGCGTGG-3′; primer B: 5′-CGGGTTCGGTTTATCAAG-3′; primer C: 5′-CACTAACATAGAGCTACG-3′; and primer D: 5′-CAGTTGTTGTTGGATGAC-3′.

PCR Analysis on Individual Mutant Embryos
-----------------------------------------

Genomic DNA from individual embryos was prepared as described by [@B32]. *kak^V104^/*SM6B, *Cy*, *Roi*, *al*, *dp*, *cn*, *sp*, P\[*ry* ^+^, *eve-lacZ*\] embryos were collected, aged, permeabilized in heptane/PBS mixture, rinsed, and stained for X-gal for 1.5 h. White embryos were selected, squashed in Gloor and Engel\'s buffer (10 mM Tris, pH 8.2, 1 mM EDTA, 25 mM NaCl, 200 μg/ml proteinase K), and incubated at 37°C for 30 min and at 95°C for 2 min. For each PCR reaction, 1--2 μl of this lysate was used.

Cloning of groovin/kakapo cDNA and Molecular Analysis
-----------------------------------------------------

Anti-Grv monoclonal antibody (mAb\#19) was used to screen a *Drosophila* embryonic (9--12 h) expression library cloned in λgt11 ([@B52]). A single clone (Φ43d) was isolated, and it exhibited a similar pattern of expression, by in situ hybridization, as that revealed by the mAb\#19 staining. A total of 12,989 bp of *kak* cDNA sequence was isolated by successive screens with 5′-end fragments from isolated clones (Φ9-1-1, Φ4, Φ6, Φ6P, and Φ3). The most 5′ cDNA sequences (1--3, 13, 700PCR, and 800V) were isolated by PCR amplification from the phage expression library. All clones and amplified fragments were tested by in situ hybridization, and they exhibited an EMA cell--specific expression pattern.

DNA fragments subcloned in Bluescript (Stratagene, La Jolla, CA), λgt11 DNA, or PCR products were sequenced by an automated sequencer (Applied Biosystems, Foster City, CA). The sequences were analyzed by AutoAssembler DNA sequence assembly software package (version 1.0.3; Applied Biosystems).

For Northern analysis, a *kak* cDNA 4.6-kbp (position 6394--10993) probe was used.

Sequence and Computer Analysis
------------------------------

The predicted amino acid sequence was analyzed by the Wisconsin Package Version 9.1 (Genetics Computer Group \[GCG\], Madison, WI). Nonredundant databases were searched against the Kak amino acid sequence. The results of BLASTP 1.4.11 ([@B2]), which are representative of other results obtained, have indicated homology to the dystrophin protein family. The region of Kak internal repeats was identified using COMPARE and DOTPLOT, with the parameters window length = 100, stringency = 39--45 points (not shown). The repeats were aligned using PILEUP, and the output file was further processed using the SeqVu 1.0.1 program (The Garavan Institute, Sydney, Australia). The repeat border definition is in line with the dystrophin consensus CS1 ([@B26]). The Kak consensus repeat contains a similar amino acid content and order as the dystrophin consensus CS1 (46% identity and 51% similarity). The putative Leucine-zipper domains were identified by the MOTIFS program of GCG. The results of BLASTP 1.4.11 also indicated that Kak COOH terminus shares a homology domain with additional proteins in the database (Fig. [2](#F2){ref-type="fig"} *B*). The proteins that share this homology domain with Kak COOH terminus are human brain mRNA (KIAA0465 protein; sequence data available from GenBank/EMBL/ DDBJ under accession number [AB007934](AB007934)), human GAR22 (accession number [Y07846](Y07846)), mouse Gas2 (accession number [M21828](M21828)), human Gas2 (accession number [U95032](U95032)), and a putative open reading frame (ORF) from *Caenorhabditis elegans* ([@B49]; accession number [U40800](U40800); gi1065956).

Results {#Results}
=======

Cloning of groovin/kakapo
-------------------------

We have previously identified a monoclonal antibody (mAb\#19), which stained the EMA cells in a specific manner, and according to its prominent staining along the embryonic segmental grooves, we named the corresponding antigen Groovin ([@B46]). To gain an insight into the molecular nature of Groovin, we used mAb\#19 to screen an embryonic cDNA expression library. Based on this screen, we isolated a single reactive phage clone (Φ43d). In situ hybridization with the isolated 43d cDNA insert exhibits embryonic expression in the EMA cells (similar to the expression pattern obtained with the monoclonal antibody). The specific reactivity of mAb\#19 with the expressed protein sequence of 43d cDNA was verified by the following experiment. The cDNA insert from Φ43d was subcloned into a FLAG-tag-- containing vector to enable transfection of human cultured 293 cells. After transfection with the 43d-containing construct, cells were lysed, immunoprecipitated with anti-FLAG antibody, and subjected to Western analysis with mAb\#19. A specific reactive band of the expected 43-kD size was detected only in the transfected cells (Fig. [1](#F1){ref-type="fig"} *A*). The selected cDNA clone was subsequently used to screen and clone continuous cDNA sequences. As shown below, we have demonstrated that *groovin* is the structural gene for the *kakapo* ([@B31]) locus. We will refer to this gene as *kakapo* (*kak*).

The contiguous nucleotide sequence of partially overlapping cDNA clones spans 12,989 bp and contains a single continuous ORF (positions 1--12453) encoding 4,151 amino acids (Fig. [1](#F1){ref-type="fig"} *D*). The most 5′ sequences of the cDNA, encoding the putative initiator methionine of the ORF, were cloned by [@B23]. Thus, the complete cDNA of *kak* spans 17,420 bp and encodes a novel protein of 5,497 amino acids of a putative size of 627 kD. All the amino acid positions indicated in this paper refer to the amino acid sequence presented in Fig. [1](#F1){ref-type="fig"} *D*, which does not include the two alternative NH~2~-terminal spliced forms described in [@B23].

In situ hybridization to polytene chromosomes using a 1.4-kbp fragment of *kak* cDNA (position 11588--12989) indicates that *kak* maps to a single location on the second chromosome, at position 50C3-6 of the cytological map (not shown). Northern blot analysis using a *kak* cDNA fragment of 4.6 kbp (position 6394--10993) revealed two transcripts of ∼17.6 and ∼15.4 kbp (Fig. [1](#F1){ref-type="fig"} *B*). Western blot analysis of protein extracts from embryos (12--20 h) shows a major protein band in the ∼400-kD size range (determined by comparing the Kak band to that of laminin A chain, Fig. [1](#F1){ref-type="fig"} *C*). This major band is seen when using polyclonal antibodies raised against the protein product of a 4.6-kbp fragment of *kak* cDNA (encoding for amino acids 2136--3668) fused to GST. The specificity of the antibody is demonstrated by its failure to react with extracts derived from embryos homozygous for a deficiency (Df(2R)MK1; see Materials and Methods) that uncovers the *kak* locus (Fig. [1](#F1){ref-type="fig"} *C*). The discrepancy between the calculated protein molecular mass (627 kD) and the 400-kD band obtained in Western analysis may be indicative of posttranslational modifications of the translated sequences.

Kakapo Is a Cytoskeletal-associated Protein
-------------------------------------------

The primary amino acid sequence of Kak reveals several domains and motifs that show high degrees of similarity to three distinct vertebrate cytoskeletal-related protein families, namely plakin ([@B34]), dystrophin ([@B27]), and Gas2/GAR22 ([@B36]; [@B53]) (Fig. [2](#F2){ref-type="fig"}, *A--C*).

The NH~2~-terminal region of Kak is homologous to the NH~2~-terminal domain of members of the plakin family of cytoskeletal cross-linker proteins, comprising plectin, BPAG1, and ACF7 ([@B34]). These large proteins link actin microfilaments and intermediate filaments to the plasma membrane at specialized attachment sites, called hemidesmosomes. Abnormal function of various plakin family members leads to skin (e.g., bullous pemphigous) as well as neurological (e.g., dystonia musculorum) disorders (for reviews see [@B34]; [@B20]). The region of similarity between Kak and plakin family members includes the actin binding region but does not exhibit similarity to the intermediate filament--associated domain; homologies with plakin family members are described in more detail in [@B23].

The central region of Kak (amino acids 408--3574) consists of 22 repeats, 105--113 amino acids long (Figs. [1](#F1){ref-type="fig"} *D* and [2](#F2){ref-type="fig"} *A*). A computerized search has indicated that the central region of Kak shares sequence similarity (∼20% identity) with spectrin-like repeats present in an array of cytoskeletal-associated proteins, including dystrophin, α-actinin, and spectrin ([@B13]). These repeats are predicted to adopt a triple-helical conformation ([@B41]). In dystrophin, the multiple repeat domain functions as a spacer between the NH~2~-terminal actin-binding domain and the COOH-terminal domain associated with a group of membrane proteins ([@B14]). The consensus sequence deduced from the alignment of the spectrin-like repeats in Kak shares 46% identity (51% similarity) with the human dystrophin repeat consensus, CS1 ([@B26]) (Fig. [2](#F2){ref-type="fig"} *A*). This similarity suggests the presence of a similar domain containing multiple spectrin-like, triple-helical repeats in the central region of Kak protein. This region also contains five Leucine-zipper motifs (Figs. [1](#F1){ref-type="fig"} *D* and [2](#F2){ref-type="fig"} *C*).

A somewhat lower degree of similarity between the Kak COOH-terminal domain (sequence 3725--3793) and the region in dystrophin containing the two EF-hand motifs is also observed (not shown). The COOH-terminal domain of dystrophin-related proteins is highly conserved ([@B33]) and includes a WW domain, implicated in mediating interactions with the transmembrane protein, β-dystroglycan ([@B24]). This domain also includes two putative Ca^2+^-binding EF-hands ([@B25]) and a region involved in the binding to members of the syntrophin family of PDZ domain--containing proteins ([@B1]; [@B42]). The similarity between Kak and dystrophin in the COOH-terminal domain is detected only along the EF-hand motifs (∼30% identity along a sequence of 70 amino acids). This limited similarity may suggest that although Kak does not appear to be a dystrophin family member, these genes may share a common ancestor.

The COOH-terminal region of Kak shows sequence conservation with yet another family of cytoskeletal-related proteins representative by the Gas2/GAR22 proteins ([@B36]; [@B53]) (Fig. [2](#F2){ref-type="fig"} *B*). Mouse Gas2, a member of this protein family, belongs to a set of proteins that was shown to be selectively expressed in growth-arrested cells in culture ([@B36]). It is a highly regulated protein ([@B9]; [@B29]) that interacts with the microfilament system ([@B9]; [@B8]). Deletion analysis of the Gas2 protein suggests that the region in Gas2 that is homologous to Kak has a significant function in cytoskeletal organization ([@B10]). During apoptosis, Gas2 is cleaved by ICE proteases, presumably leading to microfilament derangement ([@B10]). An additional partially cloned cDNA species of unknown function from human brain ([@B39]) exhibits a high level of identity to the COOH-terminal domain of Kak protein (Fig. [2](#F2){ref-type="fig"} *B*). This similarity extends beyond the Gas2 homology domain and exhibits 40% overall identity along the entire 1,658--amino acid sequence available in the data base. It is not clear whether this partially cloned cDNA represents a human Kak homologue. In addition, a putative protein from *C*. *elegans* ([@B49]) shares domain contents with Kak, including plectin, dystrophin, and Gas2/ GAR22-like domains mentioned above (see also [@B23]). The function of this putative protein is yet to be elucidated.

Taken together, the deduced amino acid sequence of Kak (summarized in Fig. [2](#F2){ref-type="fig"} *C*) predicts a novel large intracellular protein that carries two distinct cytoskeletal-associated domains separated by a spacer consisting of elongated triple-helical spectrin-like repeats. At the NH~2~-terminal domain, Kak may interact with actin microfilaments, while at its COOH terminus, it may be associated with membrane structures or with additional cytoskeletal components. The similarities between Kak and its *C*. *elegans* and putative human homologues suggests that Kak structure is conserved through evolution.

Kakapo Marks the Epidermal Muscle Attachment Cells in the Embryo
----------------------------------------------------------------

The expression pattern of *kak* mRNA and protein during various stages of embryonic development were characterized (Fig. [3](#F3){ref-type="fig"}). *kak* mRNA expression is restricted to ectodermally derived cells, and is initially observed in extended germ band embryos during late stage 11. During germ band retraction, the mRNA is expressed by cells along the future segmental grooves and in a small cluster of ectodermal cells at the middle of each hemi-segment (Fig. [3](#F3){ref-type="fig"}, *A--D*). Since at these stages the somatic myotubes have not yet extended their leading edge into their final position, we assume that the initial activation of *kak* transcription is independent of muscle-dependent cues.

The expression of Kak protein was studied using a polyclonal antibody raised against a bacterially expressed cDNA fragment from the COOH-terminal region. The protein expression pattern of Kak follows its mRNA expression and is apparent from stage 14 of embryonic development. During the final stages of muscle development (e.g., stage 16), high levels of Kak protein are detected in muscle-bound tendon cells, as demonstrated in embryos double-labeled for Kak and myosin (Fig. [3](#F3){ref-type="fig"}, *G--I*). Kak protein is concentrated at the circumference of the tendon cell, presumably along the tendon cell plasma membrane (Fig. [3](#F3){ref-type="fig"} *J*). Low levels of Kak protein are observed in other tissues, including epidermal cells and chordotonal organs (not shown).

The Isolation of Mutations in the kakapo Locus
----------------------------------------------

To gain a functional insight as to the role of Kak during embryonic development, we screened for EMS-induced mutations that are lethal when crossed with Df(2R)MK1, a deletion that uncovers the *kak* locus. We recovered 15 lethal mutations that fall into several complementation groups. One allele designated A405 failed to complement a collection of seven alleles of the *kak* gene ([@B31]). A genetic screen ([@B48]), similar to that of [@B31], identified a complementation group that proved to be allelic to *kak*. A representative allele from this complementation group, V104, failed to complement the A405 allele. We concluded that A405 is allelic to *kak*.

We performed molecular analysis of *kak^V104^* genomic DNA and identified a chromosomal rearrangement in the 3′ end region of the *kak* gene (see Fig. [4](#F4){ref-type="fig"}). We carried out Southern analysis with an array of probes covering the entire *kak* cDNA sequence and identified a region in the COOH terminus of the gene that exhibited a distinct pattern of restriction fragments. The corresponding genomic region was sequenced from the parental (FRT42D) genomic DNA. To further narrow down the region containing the chromosomal rearrangement, we used smaller genomic sequences as probes and tested their potential to recognize the rearrangement. We identified two sequential genomic sequences (AB and CD; see map in Fig. [4](#F4){ref-type="fig"} *A*) that detect a rearrangement in *kak^V104^* mutant chromosome in Southern analysis but react with distinct restriction fragments in the rearranged chromosome (Fig. [4](#F4){ref-type="fig"} *B*). Thus, the rearrangement in *kak^V104^* mutant chromosome is likely to be introduced in the genomic region that includes both fragments (see map in Fig. [4](#F4){ref-type="fig"} *A*).

To further characterize the rearrangement in *kak^V104^*, we performed PCR, followed by sequence analysis of individual homozygous *kak^V104^* embryos in the suspected rearranged genomic region (see Materials and Methods for details). Although the size and sequence of the AB and CD genomic fragments was not altered in the mutant embryos, we were unable to amplify the 2.8-kbp AD fragment, which includes both fragments and an additional 400-nucleotide fragment in between (Fig. [4](#F4){ref-type="fig"} *C*). This result together with the Southern analysis (described above) strongly argues that the x ray--induced rearrangement falls into the 400-nucleotide stretch between the AB and CD fragments (Fig. [4](#F4){ref-type="fig"} *A*, *hatched box*).

The rearrangement at the *kak* 3′ end region in *kak^V104^*chromosome predicts an alteration within the last 280 amino acids of the mutant Kak protein. Indeed, Western analysis of individual homozygous *kak^V104^* embryos with the anti-Kak polyclonal antibody reveals a truncated protein that runs slightly faster compared with the wild-type protein (Fig. [4](#F4){ref-type="fig"} *D*). Thus, it is suggestive that the alteration in *kak* 3′ end region leads to premature translational termination.

Taken together, the Southern, PCR, and Western analyses are consistent with the notion that a DNA rearrangement in the *kak* gene was introduced in the *kak^V104^* chromosome. Molecular analysis described in the accompanying paper ([@B23]) shows that in *kak* P-element mutant allele (*l(2)k03010*), the P-element is inserted at the 5′ intronic sequences of the *kak* gene. Our molecular analyses and the indication that *kak^V104^* is allelic to *kak^l(2)k03010^* mutant strongly argue that these mutations affect the *kak* gene.

The EMA Cells in kak Mutant Embryos Fail to Differentiate Properly
------------------------------------------------------------------

To elucidate the function of *kak* in EMA cell differentiation, we analyzed embryos transheterozygous for *kak^V104^*/ *kak^A405^* alleles for expression of various markers characteristic of tendon cell terminal differentiation, including Stripe, Delilah, and *β1 tubulin* mRNA. This analysis shows that an excess of EMA cells, marked by the expression of Stripe and Delilah, is observed at a number of sites in the epidermis (Fig. [5](#F5){ref-type="fig"}). This phenotype is particularly notable in domains in which a group of muscles extend together towards neighboring epidermal attachment cells, such as along the ventral segmental border cells, to which the four ventral longitudinal muscles bind (Fig. [5](#F5){ref-type="fig"} *B*, *arrow*). The excess in EMA cells was also observed in additional *kak* allelic combinations, e.g., embryos transheterozygous for *kak^A405^/DfMK1*. The EMS-induced *kak^A405^* allele appears to represent a severe *kakapo* allele. Although the size of Kak protein is not altered, as concluded from Western analysis of individual *kak^A405^* homozygous mutant embryos (see Fig. [4](#F4){ref-type="fig"} *D*), their mutant phenotype is quite similar to that of *kak^A405^*/*DfMK1* mutant embryos (not shown).

To further study the state of differentiation of the EMA cells in the *kak* mutant embryos, we analyzed the expression of the *β1 tubulin* gene. In wild-type embryos, the expression of the *β1 tubulin* gene is significantly elevated towards the end of tendon cell differentiation. In contrast to the expression of Stripe and Delilah, the mRNA expression of *β1 tubulin* in *kak* mutant embryos is significantly reduced, suggesting that transcription of the latter gene requires different levels of signaling (Fig. [5](#F5){ref-type="fig"} *B*). We suspected that Vein signaling, which is required for terminal differentiation of tendon cells ([@B50]), may be reduced in the mutant embryos; while there is enough signal to trigger Delilah and Stripe expression, it is not capable of inducing *β1 tubulin* transcription.

Vein Localization Is Abnormal in kak Mutant Embryos
---------------------------------------------------

Previously, we showed that the expression of *delilah*, *stripe*, and *β1 tubulin* is induced in the epidermal attachment cells as a result of the EGF-receptor pathway activation by the neuregulin-like growth factor, Vein ([@B50]). Vein protein localization is restricted to the muscle--tendon junctional site in wild-type embryos. However, in *kak^V104^*/*kak^A405^* mutant embryos, Vein protein is not localized and appears rather diffuse (Fig. [6](#F6){ref-type="fig"}). This altered pattern of Vein may explain the multiple number of cells expressing *delilah* and *stripe*; since Vein is not strictly localized at a given muscle--tendon junction site, it apparently weakly activates the EGF-receptor pathway in neighboring cells as well. We presume that the only cells that can respond to the ectopic Vein protein are the competent population of EMA cells, defined by the early expression of *stripe* (see introduction). These cells express *stripe* during early developmental stages in a muscle-independent manner and normally lose their *stripe* expression by stage 16 of embryonic development. When these competent EMA cells receive the muscle-derived Vein signal, the expression of *stripe* and *delilah* is reactivated. It appears that only this population of cells is capable of responding to Vein, since the pattern of the ectopic Stripe- or Delilah-expressing cells in the *kak* mutant embryos resembles that of the early population of Stripe-expressing cells (not shown).

The reduced levels of *β1 tubulin* mRNA in the mutant tendon cells may also result from the abnormal pattern of Vein localization, since lower levels of Vein may not be sufficient to induce maximal *β1 tubulin* expression. It therefore appears that the primary defect in *kak* mutant embryos stems from the lack of Vein accumulation at the muscle--tendon junctional site.

The Somatic Muscle Pattern Is Disrupted in kakapo Mutant Embryos
----------------------------------------------------------------

Finally, we wished to examine whether the abnormal differentiation of the EMA cells in *kak* mutant embryos is reflected by the pattern of the somatic musculature. *kak^V104^*/ *kak^A405^* mutant embryos at stage 16 of embryonic development were labeled with anti--myosin heavy chain antibody to visualize the somatic muscles, and the muscle pattern was compared with that of wild-type embryos. A significant disruption of the somatic muscle pattern is observed in *kak* mutant embryos (Fig. [7](#F7){ref-type="fig"}). In many cases, individual myotubes are not oriented correctly, and in some cases the myotube rounds up. Since Kak cannot be detected in myotubes using our antibodies, it is assumed that the somatic muscle derangement is secondary to the abnormal differentiation of the EMA cells. A similar phenotype is also observed in *stripe* mutant embryos, in which the EMA cells do not differentiate correctly ([@B19]). The similarity between the *stripe* and *kak* muscle phenotype and the reduced *β1 tubulin* mRNA expression are consistent with the conclusion that EMA cell differentiation is defective in *kak* mutants. The correct recognition between the muscle and the tendon cell is essential for arresting the extension of the myotube and establishment of the final pattern of somatic musculature ([@B50]). It appears that the muscle development in *kak^V104^*/ *kak^A405^* embryos does not represent a complete loss of function phenotype since a more severe muscle defect is observed in *kak^V104^*/*DfMK1* embryos (not shown).

Discussion {#Discussion}
==========

Intercellular inductive interactions take place continuously during development and underlie proper organogenesis. In this paper, we describe a novel protein, Kakapo, that is essential for the inductive interactions between muscles and their epidermal attachment cells during *Drosophila* embryogenesis. The accompanying papers describe additional functions for this protein in epidermal integrity and cytoskeletal arrangement ([@B23]) and in proper formation of the neuromuscular junction ([@B30]).

Our results are consistent with a model in which Kak is essential for the concentration of Vein at the muscle--tendon junctional site. This localization is important for the accumulation of Vein protein at high levels; such levels are critical to ensure that a single EMA cell responds to the approaching muscle by turning on its differentiation program towards a fully developed tendon cell.

Possible Mechanisms by which Kakapo Exerts Its Function
-------------------------------------------------------

Kak is an intracellular protein that exhibits two structural domains associated with cytoskeletal elements: the actin binding domain at its NH~2~-terminal and the Gas2 domain at its COOH-terminal end, spaced by an elongated, multiple spectrin-like repeat domain. How could this intracellular protein affect the localization of Vein at the extracellular matrix surrounding the EMA cell? We consider at least two possibilities, which are not mutually exclusive. The first is the association of Kak with the unique cytoskeletal network of the EMA cell, which is critical for its polarized organization. Tendon cell polarity may be essential for maintaining the characteristic junctional complexes formed between the basal surfaces of the EMA cell and the muscle cells. The space between these junctional complexes contains many extracellular matrix proteins, some of which may posses a Vein binding function. Impaired tendon cell polarity may lead to the loss of the putative Vein-binding component(s). Alternatively, Kak may be associated with a transmembrane protein(s) responsible for Vein localization either by direct binding or by association with additional extracellular matrix components that may directly bind Vein. Immunoprecipitation experiments with anti-Kak antibody (Strumpf, D., and T. Volk, unpublished) indicated that Kakapo forms protein complexes containing the extracellular protein Tiggrin ([@B17]). These results favor the latter possibility that Kak is directly associated with protein complexes that may be important for Vein binding. The reduced amount of electron-dense material observed at the muscle--tendon junction site in the *kak* mutant embryos described in [@B30] is in line with both mechanisms mentioned above.

The excess number of Stripe- and Delilah-expressing cells in the *kak* mutant embryos may be attributed to the dispersed levels of Vein, which could induce partial activation of the EGF-receptor signaling pathway in neighboring cells. An alternative explanation is that muscle-dependent differentiation of tendon cells may be accompanied by lateral inhibition of neighboring cells. The differentiated tendon cell may activate the Notch-signaling pathway in the surrounding cells. Aberrant contacts between tendon cells and their neighboring EMA competent cells in the *kak* mutant embryos may prevent efficient lateral inhibition, resulting in an excess of Stripe- and Delilah-expressing cells. An observation that supports this possibility is that an excess in *β1 tubulin*--expressing cells is detected in *Delta* mutant embryos (Volk, T., unpublished). Delta, a well-characterized Notch ligand, mediates lateral inhibition in a large array of tissues during embryonic and adult development ([@B4]). The lack of Delta may prevent lateral inhibition of the competent EMA cells, leading to their differentiation into *β1 tubulin*-- expressing cells. The impaired integrity of the epidermis described by [@B23] is consistent with this explanation.

Kak May Be Part of a Regulatory Mechanism That Controls Vein Activity
---------------------------------------------------------------------

The possibility that Kak directly mediates a Vein-induced signaling cascade was excluded since ectopic expression of Vein in *kak* mutants can activate *delilah* gene expression in epidermal cells, as in wild-type embryos (not shown). However, in this experiment the embryos expressing ectopic Vein are exposed to an excess of Vein protein compared with the physiological conditions. High levels of Vein may compensate for a mechanism responsible for accumulation of Vein at specific sites. Recent findings ([@B38]; [@B51]) suggest that Vein is a relatively weak activator of the EGF-receptor signaling pathway, compared with Spitz, the TGFα *Drosophila* homologue. Thus, Vein-mediated signaling may be susceptible to an as-of-yet-uncharacterized regulatory mechanism that controls its localization and accumulation essential for proper receptor activation. Kak may be part of such a regulatory mechanism.

The Function of Kak in the Wing May Be Comparable with Its Function in Muscle-dependent Tendon Cell Differentiation
-------------------------------------------------------------------------------------------------------------------

The *kak* alleles were initially isolated on the basis of their ability to induce a wing blistering phenotype ([@B31]). The blistering phenotype is explained by defects in adhesion between the dorsal and ventral aspects of the wing epithelia ([@B31]; [@B18]). The failure of *kak* mutant cells to adhere to wild-type counterpart cells in the wing may result from the impaired differentiation of the mutant cells. Interestingly, Vein mRNA is expressed at high levels in the wing intervein domain after puparium formation ([@B40]). This domain includes the cells that adhere to each other at the pupae stage to form the adult wing. The role of Vein in this process is yet to be elucidated. By analogy to its involvement in mediating Vein localization in the embryo during the process of muscle-dependent differentiation, Kak may contribute to the correct localization of Vein protein at the junction formed between the dorsal and ventral intervein epithelia. This localization may be essential for the correct activation of the EGF-receptor pathway and for the proper differentiation of the wing epithelial cells.

Possible Kak-like Activity in Vertebrate Neuromuscular Junction Formation
-------------------------------------------------------------------------

Several lines of evidence suggest that the process of Vein-mediated tendon cell differentiation shares molecular similarities with neuromuscular synapse formation. The secretion of Vein by the approaching muscle cell, and its restricted localization at the muscle--tendon junctional site, is reminiscent of the specific localization of its mammalian homologue Neuregulin (NRG or ARIA), which is secreted from the motor nerve endings and is localized at postsynaptic sites. NRG is essential for the activation of synapse-specific gene transcription in the postsynaptic muscle nuclei ([@B15]; [@B16]; [@B11]). In a similar manner, Vein is required to positively regulate the transcription of tendon-specific genes, such as *delilah* and *β1 tubulin* ([@B50]).

The aberrant formation of the *Drosophila* neuromuscular junction in *kak* mutant embryos (described by [@B30]) is consistent with an important role for this gene in both Vein-mediated tendon cell differentiation and neuromuscular junction formation, supporting a molecular correlation between these processes.

The mechanism that is responsible for the restricted localization of NRG together with its erbB receptors is yet to be elucidated. However, when this localization is defective, the structure and proper function of neuromuscular synapses is disrupted ([@B35]). Thus, vertebrate Kak-like proteins may be part of an intracellular mechanism that is essential for restricting synaptic sites to specific muscle--subcellular domains.
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![The V104 mutation falls within the *kak* locus. (*A*) A scheme describing the COOH-terminal genomic region of the *kakapo* gene and the rearrangement break point deduced from Southern and PCR analysis. In the upper scheme, the restriction sites of EcoRI (*R*) and AccI (*A*) are indicated. Horizontal arrows *A--D* represent the relative location of the primers used for amplifying the probes AB, CD, and AD described below. The vertical arrow points to the rearrangement region (*hatched box*). In the lower scheme exons (*black boxes*), stop codon (*asterisk*) and noncoding sequences (*open box*) are indicated. The triangle marks amino acid position 3871 in Kak protein sequence. (*B*) Southern analysis of EcoRI- or AccI-digested genomic DNA isolated from an isogenized *b pr cn bw* strain (WT), *kak^V104^/b pr cn bw* strain (*V104*), or the parental FRT42D strain (*Par*), reacted with either AB or CD probes. The AB and CD probes flank the rearrangement point in *kak^V104^* chromosome and were generated by PCR amplification using primers A and B, or C and D (see scheme in *A*). Note that while both AB and CD probes react with a single 5-kbp EcoRI band in all chromosomes, in V104 the AB probe recognizes an extra band of 3 kbp, while CD probe recognizes a distinct 5.5-kbp band (*left arrowheads*). Likewise, probe AB recognizes a 2.3-kbp AccI band common to all chromosomes, while probe CD recognizes, in addition to a 2-kbp common band, an extra 2.8-kbp band present uniquely in the V104 chromosome (*right arrowhead*). Notice that because of the presence of an AccI site between the rearrangement point and the AB sequence (see *A*), the AB probe is not expected to recognize the chromosomal rearrangement in V104. (*C*) PCR analysis on individual homozygous *kak^V104^* (V104) embryos selected as described in Materials and Methods, with either A and B (*A*+*B*) or C and D (*C*+*D*) primers flanking the rearrangement point, or with A and D primers (*A*+*D*) located 3′ and 5′ to the rearrangement point (see scheme in *A*). Note that both AB and CD DNA fragments are amplified in the PCR reaction on template DNA taken from two individual *kak^V104^*mutant embryos, or from the parental FRT42D genomic DNA. However, the 2.8-kbp AD PCR fragment is amplified only from the FRT42D genomic template DNA and not from the template DNA taken from the *kak^V104^*mutant embryos. The sequence of all PCR fragments was verified by sequence analysis. (*D*) Western analysis of *kak^V104^*or *kak^A405^* mutant embryos. Single *kak^V104^*or *kak^A405^* homozygous mutant embryos were selected (see Materials and Methods), boiled in protein sample buffer, and analyzed in Western using anti-Kak polyclonal antibody. A representative lane of the Kak-reactive band from the *kak^V104^*mutant embryos (V104) runs slightly faster relative to the wild-type (WT) band. The size of Kak protein in *kak^A405^* mutant embryos (A405) is similar to that of the wild-type band.](JCB9804096.f4){#F4}

###### 

*kakapo* is homologous to cytoskeletal-associated proteins. (*A*) Sequence alignment of the Kak repeats. The amino acid sequence of the 22 repeats marked in Fig. [1](#F1){ref-type="fig"} *D* are aligned. Gaps (−) were added to optimize alignments. The numerical order of the repeats is shown on the left and the sequence position of the residue that ends each repeat is given on the right. The length of each repeat is indicated in parenthesis. The repeat consensus sequence (KakCS) indicates amino acids that are conserved in a given position in 11 or more repeats and/or share this position with a related amino acid(s) (designated above KakCS sequence) and are shaded in the repeat alignment. The alignment between Kak repeat consensus and human dystrophin repeat consensus CS1 (h-DysCS1; [@B26]) is presented at the bottom of this figure. Gaps (−) in h-DysCS1 were added manually to optimize alignment with KakCS. Identical residues are marked with "\|" and related amino acids are marked by "!". KakCS shares 46% identity (51% similarity) with h-DysCS1. (*B*) Kak shares a homology domain with proteins of the Gas2/GAR22 family of intracellular proteins and with a partially cloned cDNA KIAA0465 from human brain. Alignment of Kak, human brain cDNA (*hbrain*), GAR22, mouse Gas2 (*mGas2*), human Gas2 (*hGas2*), and a putative ORF from *C*. *elegans* (*Celedyslk*) homology domains is shown. The amino acid sequence of the homology domain in each of the aligned proteins was compared with that of Kak. The degree of identity is as follows: 72%, hbrain; 50%, GAR22; 44%, mGas2 and hGas2; and of the *C*. *elegans* protein 27% identity over the first 36 aligned amino acids and 71% identity over the last 39 amino acids. Shaded positions represent residues that are identical or similar to the corresponding residue in Kak. The start and end amino acid positions are indicated. In "Celedyslk," a stretch of 96 amino acids was removed to optimize the alignment (the position is marked by an *arrowhead* under the sequence). (*C*) A schematic linear representation of the Kak protein, showing the relative positions of the putative actin binding site (*checkered box*) and plectin homology region (*hatched box*) (described in [@B23]), putative Leucine-zipper domains (*L*), Kakapo repeats (*gray boxes*), and the Gas2/GAR22 homology region (*G*).
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###### 

Structural and molecular analysis of *kakapo*. (*A*) The specific reactivity of mAb\#19 with the expressed protein sequence of the cDNA clone isolated from phage Φ43d (representing the COOH-terminal end of Kak) is demonstrated. The 43d cDNA insert was subcloned in frame to FLAG-tagged--containing vector. This construct was used to transfect 293 human cultured cells, and the extract from the transfected cells was first immunoprecipitated with anti-FLAG antibody and then subjected to Western analysis with mAb\#19. While mAb\#19 reacts with the expected 43-kD polypeptide in the transfected cells (*arrowhead* in lane *Φ43d*), it did not react with any band in the control nontransfected cells (*Con*). (*B*) Northern blot analysis of poly (A+) RNA prepared from 12--20-h-old embryos. The *kak* mRNA was detected using a *kak* cDNA fragment of 4.6 kbp (nucleotides 6394--10993 of the cDNA). RNA molecular marker sizes are shown on the right. *kak* cDNA probe hybridizes specifically with two transcripts of ∼15.4 and ∼17.6 kbp (*arrowheads*). (*C*) Western blot analysis of wild-type (Df(2R)MK1/+) or mutant (Df(2R)- MK1/Df(2R)MK1) embryos with anti-Kak polyclonal antibody. Each lane represents extract made from 30 embryos (stages 16-- 17). Mutant embryos were selected according to their phenotype. The anti-Kak antibody recognizes a specific band of ∼400 kD. We used as markers (shown on the right) the *Drosophila* laminin A chain (∼400 kD) and standard molecular mass markers (only the ∼180 kD size is shown). The specificity of the polyclonal antibody is indicated by its lack of reactivity with extracts from embryos homozygous for Df MK1. (*D*) The deduced amino acid sequence of Kak. The 4,151--amino acid sequence was derived from the single ORF in the 12,989-nucleotide cDNA sequence. The sequence presented lacks an initiator methionine. *kak* ORF terminates at position 12454 and is followed by a putative polyadenylation signal at position 12979. The amino acid residue number is indicated to the right of each line. Leucine residues in potential Leucine-zipper domains are in bold text. Kakapo repeats are delineated with bent arrows and are numbered. The presented sequence data are available from EMBL nucleotide sequence database under accession number [Y09430](Y09430). (Note: All the amino acid positions indicated in this paper refer to the amino acid sequence presented in Fig. [1](#F1){ref-type="fig"} *D*, which does not include the two alternative NH~2~-terminal spliced forms described in [@B23].)
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![*kakapo* mRNA and protein expression pattern. In situ hybridization with *kak* cDNA fragments (*A--D*) and antibody staining using anti-Kak polyclonal antibody (*E--J*) show the dynamics of Kak expression during distinct developmental stages. *kak* mRNA expression starts at the extended germ-band (stage 11) as segmented patches in the ectoderm (*A*). In late stage 11, the mRNA is detected along the segment borders (*B*). After germ-band retraction (stage 14), *kak* mRNA expression is also seen within the segments (*C*). At stage 16, the expression pattern becomes localized at all the EMA cells (*D*). Kak protein expression follows that of the mRNA expression at stages 14 and 16 (*E* and *F*, respectively). The complementary pattern of the somatic muscle pattern with that of EMA cells is shown by double labeling the embryos with anti--myosin heavy chain (*green*) and anti-Kak (*red*) in *F--I*. *G--I* represent single (*G* and *H*) and overlap (*I*) images of the same embryo. Arrows in *G--I* indicate the same row of EMA cells bound to an array of ventral longitudinal muscles. Notice the association of Kak protein with the circumference of the EMA cells in *G--I*, and in the cross section of an embryo labeled with anti-Kak antibody at stage 16 (*J*; EMA cell marked by an *arrowhead*; *m*, myotube).](JCB9804096.f3){#F3}

![Tendon cell differentiation is abnormal in *kak* mutant embryos. Staining with anti-Stripe (*A* and *B*), anti-Delilah (*C* and *D*), and in situ hybridization with *β1 tubulin* probe (*E* and *F*) is analyzed in *kak^V104^/kak^A405^* mutant embryos (*B*, *D*, and *F*), and compared with that of wild-type (*A*, *C*, and *E*) embryos. An excess in Stripe- or Delilah-expressing EMA cells is observed in the *kak* mutant embryos (compare *arrows* in *A* and *B*, and in *C* and *D*). *β1 tubulin* expression in all the EMA cells is significantly reduced (*F*), as compared with its expression in the chordotonal organs (*ch*, *arrowhead*).](JCB9804096.f5){#F5}

![Abnormal localization of Vein protein in the muscle-- tendon junction site of *kak* mutant embryos. Wild-type and *kak^V104^/kak^A405^* mutant embryos were stained with anti-Vein antibody. The localization of Vein protein in wild-type embryos is prominent at the muscle--tendon junction site (*arrowhead* in *A*). In *kak* mutant embryos, the localization of Vein is diffuse in the region of muscle--tendon junction (*arrowhead* in *B*).](JCB9804096.f6){#F6}

![The somatic muscle pattern is deranged in *kak* mutant embryos. Wild-type embryos (*A* and *C*) and *kak^V104^/kak^A405^* mutant embryos (*B* and *D*) were stained with anti--myosin heavy chain antibody. Lateral (*A* and *B*) and ventral (*C* and *D*) views of the embryos are shown. The pattern of the somatic muscles is disrupted in *kak* mutant embryos. Notice that the muscles continue to extend their leading edge ignoring the attachment sites (*arrowhead* in *D*). In some cases, muscles are missing (e.g., compare *arrow* in *B* to *A*), and some rounded muscles are also observed (*arrowhead* in *B*).](JCB9804096.f7){#F7}
